PRMT3 and hepatocellular carcinoma: Since we found that PRMT3 mRNA was upregulated by 4.35-fold in HCCs from OXA-based HAIC non-responders (Fig. 1e), we examined whether PRMT3 expression was affected by OXA treatment in HCC cells.